ICCM

NASDAQ

Icecure Medical

$2.81
-0.83 (-22.80%)
2026-06-09 00:00
Healthcare Medical Devices
-- --

Short Interest (1 Year)

% of Volume Sold Short
Market Cap
$18.5M
P/E Ratio
N/A
52W Low 52W High
$0.12 $5.69
Volume
138K
Analyst Rating
Hold
Target: $3

About Icecure Medical

IceCure Medical Ltd, a commercial-stage medical device company, engages in the research, development, and marketing of cryoablation systems, disposables, and technologies for treating tumors in the United States, Japan, India, China, Israel, and internationally. The company offers the ProSense system, a single probe cryoablation system for the treatment of malignant breast tumors, as well as its associated disposables, including CryoProbes needles, and guiding needles/introducers; and IceSense3 ...

Employees 67

Latest News

Benzinga - 21d ago

IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked
Benzinga - 27d ago

IceCure Granted 180-Day Extension by Nasdaq to Regain Compliance with Minimum Bid Requirement
Benzinga - 28d ago

IceCure Reports First Quarter 2026 Financial Results: ProSense® Sales Increase Substantially in the U.S. and North America

Financial Highlights

Annual Quarterly
Year Revenue Op Margin Net Income Free Cash Flow
2025 $3.4M -446.7% -$15.1M -$14.5M
2024 $3.3M -476.9% -$15.3M -$12.5M
2023 $3.2M -482.4% -$14.7M -$12.0M
2022 $3.1M -542.6% -$17.2M -$13.4M
2021 $4.1M -235.0% -$10.1M -$12.1M
View Full Financial Statements